Health Care: Drugs

Exelixis Inc (EXEL: NASDAQ)

$1.7 0.08 | 4.94%
09/17/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 1.62
52 Week High 8.41
52 Week Low 1.60
Avg. Daily Vol. (Mil) 5.23
Beta (3 year) 2.14
Share Related Items
Mkt Cap (Mil) 316.08
Shares Out (Mil) 195.11
Float (Mil) 96.22
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 1.40
Current Ratio 1.50
LT Debt/ Equity 78.23
Total Debt / Equity 107.61
Valuation Ratios
Price Earnings n.a.
Price/Sales 14.85
Price/Book 97.46
Price/Cash Flow -1.20
Per Share Data
Earnings -1.51
Sales 0.11
Book Value 0.02
Cash Flow -1.31
Business Summary
Exelixis Inc is a biotechnology company that develops small molecule therapies for the treatment of cancer.
General Information
210 East Grand Avenue
South San Francisc, CA 94080
www.exelixis.com
Industry : Drugs
Sector: Health Care
Employees: 227
CEO: Dr. Michael M. Morrissey
Short Interest
Current Month (Mil) 49.37
Previous Month (Mil) 48.19
Short Interest Ratio (Days) 21.70
Management Effectiveness
Return on Equity n.a.
Return on Assets -64.90
Return on Investments -111.30
Profitability
Gross Margin 93.70
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with EXEL

Latest EXEL Headlines from TheStreet

More Financial News for EXEL

Press Releases for EXEL

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter